Wednesday, August 6, 2025

Amigo & Eucalyptus Partner to Scale AI Telehealth Globally

Related stories

From Compliance to Competitive Edge: Rethinking Third-Party Risk in AI

For years, third-party risk management (TPRM) in technology felt...

Motive Raises $150M to Boost AI and Global Expansion

Motive has announced a $150 million funding round led...

Ex-Big Tech cyber vets launch Dawnguard with $3M in stealth

Dawnguard, a cybersecurity startup on a mission to make...

Quark’s New Platform Boosts Scalable AI Content Automation

Quark Software, the global provider of content automation, intelligence...

BigID Launches AI TRiSM to Govern and Trust AI Models, Data

BigID, a leader in data security, privacy, compliance, and...
spot_imgspot_img

Strategic partnership aims to deploy AI health assistants across Australia’s largest telehealth platform serving 200,000+ patients in four countries.

Amigo, the AI infrastructure company building trustworthy agents for high-stakes environments, announced a strategic partnership with leading global telehealth provider Eucalyptus. The multi-year collaboration will integrate AI-powered health agents into Eucalyptus’s portfolio of specialized healthcare brands, beginning with the successful deployment of an AI health assistant for the company’s Juniper weight management clinic.

This partnership represents a significant step forward in addressing the critical challenge of staff shortages within the healthcare industry, where well-timed engagement often determines patient outcomes. By providing continuous, intelligent support, the AI health assistant helps maintain patient motivation and adherence to treatment plans while capturing valuable insights that inform clinical decision-making.

“We are committed to pioneering the future of digital healthcare,” said Benny Kleist, Co-Founder and Chief Strategy Officer of Eucalyptus. “Working with Amigo represents a significant step forward in our mission to make quality healthcare more accessible, allowing our clinical teams to ensure every patient receives the always-on, personalized support they need to achieve their health goals.”

Also Read: Hyperfine Launches Optive AI™ to Boost Swoop® Imaging

The initial success of June, achieving a <2% human escalation rate with 100% performance on clinical safety metrics in live deployment, establishes a new benchmark for AI care delivery and validates the potential for scaled deployment across multiple therapeutic areas.

Following this deployment, Amigo and Eucalyptus plan to expand AI-powered healthcare support across Eucalyptus’s broader network of specialized virtual clinics, each tailored to address specific therapeutic areas and patient populations.

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img